Finding an optimum immuno-histochemical feature set to distinguish benign phyllodes from fibroadenoma

Micron. 2013 May:48:34-41. doi: 10.1016/j.micron.2013.02.004. Epub 2013 Feb 22.

Abstract

Purpose: Benign phyllodes and fibroadenoma are two well-known breast tumors with remarkable diagnostic ambiguity. The present study is aimed at determining an optimum set of immuno-histochemical features to distinguish them by analyzing important observations on expressions of important genes in fibro-glandular tissue.

Methods: Immuno-histochemically, the expressions of p63 and α-SMA in myoepithelial cells and collagen I, III and CD105 in stroma of tumors and their normal counterpart were studied. Semi-quantified features were analyzed primarily by ANOVA and ranked through F-scores for understanding relative importance of group of features in discriminating three classes followed by reduction in F-score arranged feature space dimension and application of inter-class Bhattacharyya distances to distinguish tumors with an optimum set of features.

Results: Among thirteen studied features except one all differed significantly in three study classes. F-Ranking of features revealed highest discriminative potential of collagen III (initial region). F-Score arranged feature space dimension and application of Bhattacharyya distance gave rise to a feature set of lower dimension which can discriminate benign phyllodes and fibroadenoma effectively.

Conclusions: The work definitely separated normal breast, fibroadenoma and benign phyllodes, through an optimal set of immuno-histochemical features which are not only useful to address diagnostic ambiguity of the tumors but also to spell about malignant potentiality.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / pathology
  • Diagnosis, Differential
  • Female
  • Fibroadenoma / diagnosis*
  • Fibroadenoma / pathology
  • Humans
  • Immunohistochemistry / methods*
  • Pathology / methods*
  • Phyllodes Tumor / diagnosis*
  • Phyllodes Tumor / pathology

Substances

  • Biomarkers, Tumor